Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

BioCeuticals

  • Home
  •  
  • BioCeuticals



  • Most Read
  • Latest Comments
  • Fiji Kava engaged by top healthcare company for anxiety treatment
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Fiji Kava engaged by top healthcare company for anxiety treatment
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Fiji Kava engaged by top healthcare company for anxiety treatment
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Fiji Kava engaged by top healthcare company for anxiety treatment
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Fiji Kava engaged by top healthcare company for anxiety treatment
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • The Calmer Co reports monthly record of eCommerce kava sales thanks to Black Friday
    The Calmer Co reports monthly record of eCommerce kava sales thanks to Black Friday
    • News

  • Japanese beer company Kirin to acquire Blackmores
    Japanese beer company Kirin to acquire Blackmores
    • News

  • Fiji Kava questioned by the ASX for ambiguous financials and ad published by The Market Herald
    Fiji Kava questioned by the ASX for ambiguous financials and ad published by The Market Herald
    • News

  • FijiKava terminates contract with PuMate, appoints RooLife to market products in China and Australia
    FijiKava terminates contract with PuMate, appoints RooLife to market products in China and Australia
    • News

  • Fiji Kava terminates US acquisition, onboards new distributor for Taki Mai
    Fiji Kava terminates US acquisition, onboards new distributor for Taki Mai
    • News

  • Fiji Kava engaged by top healthcare company for anxiety treatment
    • News

    Fiji Kava engaged by top healthcare company for anxiety treatment

    Anxiety sufferers may soon have a new alternative natural treatment available to them with health and wellness company Fiji Kava (ASX: FIJ) to supply noble kava extract to BioCeuticals, a healthcare products company owned by Blackmores (ASX: BKL). The supply agreement will provide BioCeuticals with noble kava extract to be used in their AnxioCalm products

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.